The Utility of ¹⁸F-FDG PET/CT for Monitoring Response and Predicting Prognosis after Glucocorticoids Therapy for Sarcoidosis

Table 3

Clinical remission and relapse rates of all patients.

	CMR; ()	PMR; ()	SMD; ()
Clinical remission rates, (%)
3 months	4 (66.7)	3 (42.9)	1 (10.0)
6 months	6 (100.0)	5 (71.4)	4 (40.0)
Relapse rates, (%)
6 months	0	0 (0.0)	2 (20.0)
12 months	0	3 (42.9)	6 (60.0)
5 years	0	4 (57.1)	8 (80.0)